|
2024
|
G/S
|
Pharmaceutical preparations for the treatment of pruritus; Pharmaceutical preparations for the tr... |
|
2023
|
G/S
|
Pharmaceutical preparations for the treatment of pruritus |
|
|
Invention
|
Oral formulations of kappa opioid receptor agonists.
The invention provides formulations for ora... |
|
|
Invention
|
Oligosaccharide formulations of kappa opioid receptor agonists.
The invention provides formulati... |
|
2022
|
G/S
|
Pharmaceutical preparations for the treatment of pruritus; pharmaceutical preparations for the tr... |
|
|
Invention
|
Atopic dermatitis therapy with kappa opioid receptor agonist as adjunct to topical corticosteroid... |
|
2021
|
Invention
|
Kappa opioid receptor agonist-therapeutic antigen binding protein conjugate (ktac) compounds.
Co... |
|
|
Invention
|
Kappa opioid receptor agonist-therapeutic antigen binding protein conjugate (ktac) compounds. Con... |
|
|
Invention
|
Oral formulations of kappa opioid receptor agonists. The invention provides formulations for oral... |
|
|
G/S
|
Pharmaceutical research and development |
|
|
G/S
|
Medicines and pharmaceutical preparations for the treatment and prevention of kidney diseases; me... |
|
|
Invention
|
Oligosaccharide formulations of kappa opioid receptor agonists. The invention provides formulatio... |
|
2018
|
Invention
|
Synthetic peptide amides. 450 CYP inhibition and low penetration into the brain. The synthetic pe... |
|
|
Invention
|
Synthetic peptide amides and dimers thereof. 450 CYP inhibition and low penetration into the brai... |
|
2017
|
Invention
|
Peripheral kappa opioid receptor agonists for uremic pruritus in dialysis patients.
The inventio... |
|
2016
|
Invention
|
Uses of kappa opioid synthetic peptide amides.
The invention relates to methods of use of synthe... |
|
2015
|
Invention
|
Peripheral kappa opioid receptor agonists for hard tissue pain.
A method for preventing, inhibit... |
|
|
Invention
|
Peripheral kappa opioid receptor agonists for hard tissue pain. A method for preventing, inhibiti... |
|
2014
|
Invention
|
Uses of kappa opioid synthetic peptide amides. The invention relates to methods of use of synthet... |
|
|
Invention
|
Peripheral kappa opioid receptor agonists for preventing, inhibiting or treating nausea and vomit... |
|
2013
|
Invention
|
Method for elevating prolactin in mammals.
Methods for elevating and stabilizing prolactin level... |
|
|
Invention
|
Peripheral kappa receptor agonists for reducing pain and inflammation.
A method of treating of a... |
|
|
Invention
|
Peripheral kappa receptor agonists for reducing pain and inflammation. A method of treating of a ... |
|
2012
|
Invention
|
Synthetic peptide amides for pain. 450 CYP inhibition and low penetration into the brain. The syn... |
|
2010
|
Invention
|
Uses of substituted imidazoheterocycles. The present invention provides a method of prophylaxis, ... |
|
|
Invention
|
Synthetic peptide amides and dimeric forms thereof. 450 CYP inhibition and low penetration into t... |
|
|
Invention
|
Bicyclic pyrazolo-heterocycles. The present invention provides substituted pyrazolo-heterocycles ... |
|
2009
|
Invention
|
Substituted imidazoheterocycle derivatives. The present invention provides substituted imidazohet... |
|
|
Invention
|
Azabenzimidazolones.
Compounds are provided having the general structure of formula I:
Compoun... |
|
|
Invention
|
Azabenzimidazolones. Compounds are provided having the general structure of formula I: In formula... |
|
|
Invention
|
Uses of synthetic peptide amides. 450 CYP inhibition and low penetration into the brain. The synt... |
|
|
Invention
|
Amide or thioamide derivatives and their use in the treatment of pain.
The present invention rel... |
|
2008
|
Invention
|
Gossypium hirsutum cotton. Methods for distinguishing between cotton species by analyzing a sampl... |
|
2007
|
Invention
|
N-oxides of kappa receptor peptides.
Certain peptides which exhibit high selectivity for the kap... |
|
2005
|
G/S
|
pharmaceutical development |
